Hepcidin, haemoglobin and ferritin levels in sickle cell anaemia [1]

European Journal of Haematology

Volumn 74, Issue 1, 2005, Pages 86-88

  Ezeh, Chukwuma ^a   Ugochukwu, Cynthia C ^b   Weinstein, Jon ^c   Okpala, Iheanyi ^b  

^a LONDON BRIDGE HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c NESCOT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; C REACTIVE PROTEIN; FERRITIN; GLUTAMIC ACID; HEMOGLOBIN; HEMOGLOBIN F; HEMOGLOBIN S; HEPCIDIN; INTERLEUKIN 6; L SELECTIN; VALINE;

ADULT; ALPHA GLOBIN GENE; AVASCULAR NECROSIS; BETA GLOBIN GENE; BLOOD SAMPLING; BLOOD VESSEL OCCLUSION; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRYSTALLIZATION; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; GENE; GENE MUTATION; HAPLOTYPE; HEMOGLOBIN DETERMINATION; HEMOLYSIS; HUMAN; HYPOXEMIA; INFECTION; IRON METABOLISM; KIDNEY FAILURE; LETTER; LEUKOCYTE COUNT; MALE; MICROBIAL ACTIVITY; PATHOGENESIS; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SICKLE CELL CRISIS; STATISTICAL SIGNIFICANCE; STEADY STATE; STROKE; TISSUE INJURY;

ADULT; ANEMIA, SICKLE CELL; ANTIMICROBIAL CATIONIC PEPTIDES; CASE-CONTROL STUDIES; FEMALE; FERRITINS; HEMOGLOBIN A; HEMOGLOBIN, SICKLE; HEMOGLOBINS; HUMANS; MALE;

EID: 12444280107     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2004.00337.x     Document Type: Letter

References (20)

1. Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anaemia, a molecular disease. Science 1949;10:543-548.
2. Okpala IE. The management of crisis in sickle cell anaemia (review). Eur J Haematol 1998;60:1-6.
3. Okpala IE (ed). Epidemiology, genetics and pathophysiology of sickle cell disease. In: Practical Management of Haemoglobinopathies, 1st edn. Oxford, Blackwell Publishing, 2004:20-25.
4. Hedo CC, Aken'Ova AY, Okpala IE, Durojaiye AO, Salimonu LS. Acute phase reactants and the severity of homozygous sickle cell anaemia. J Intern Med 1993;233:467-470.
5. Serjeant GR. Sickle cell disease. Lancet 1997;350:725-730.
6. Powars DR, Meiselman HJ, Fisher TC, Hiti A, Johnson C. Beta-S gene haplotypes modulate haematologic and haemorrheologic expression in sickle cell anemia. Am J Pediatr Hematol Oncol 1994;16:55-61.
7. Ballas SK. Effect of alpha-globin genotype on pathophysiology of sickle cell disease. Pediatr Pathol Mol Med 2001;20:107-121.
8. Moran MC. Osteonecrosis of the hip in sickle cell hemoglobinopathy (review). Am J Orthop 1995;24:18-24.
9. Steinberg MH, Rodgers GP. Pathophysiology of sickle cell disease: role of genetic and cellular modifiers. Semin Hematol 2001;38:229-306.
10. Anyaegbu CC, Okpala IE, Aken'ova AY, Salimonu LS. Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia. Eur J Haematol 1998;60:267-268.
11. Okpala IE, Daniel Y, Haynes R, Odoemene D, Goldman J. Relationship between the clinical manifestation of sickle cell disease and the expression of adhesion molecules on white blood cells. Euro J Haematol 2002;69:135-144.
12. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfdorf JI, Andrews N. Inappropriate expression of hepcidin is associated with iron refractory anaemia, implications for the anaemia of chronic disease. Blood 2002;100:3776-3781.
13. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002;110:1037-1044.
14. Nemeth E, Valone EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anaemia of inflammation, is a type-II acute phase protein. Blood 2003;101:2461-2468.
15. Ganz T. Hepcidin a key regulator of iron metabolism and mediator of inflammation. Blood 2003;102:783-788.
16. Nemeth E, Rivera S, Gabayan E, et al. Interleukin-6 mediates hypoferraemia of inflammation by indicing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271-1276.
17. Andrews NC. Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest 2004;113:1251-1253.
18. Makis AC, Hatzimichael EC, Mavridis A, Bourantas KL. Alpha-2 macroglobulin and interleukin-6 levels in steady-state sickle cell disease patients. Acta Haematol 2000;104:164-168.
19. Krause A, Neitz S, Magert HJ. LEAP-1, a novel highly-disulfide bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000;480:147-150.
20. Park CH, Valone EV, Waring AJ. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276:7806-7810.